Evidence map›Paper›PMID 22110745›Full record

ArticlePloS one2011

Subtype differences in pre-coupling of muscarinic acetylcholine receptors.

Jan Jakubík, Helena Janíčková, Alena Randáková, Esam E El-Fakahany, Vladimír Doležal

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Fusion with Promiscuous GαInternational journal of molecular sciences · 2021
    Article
  5. Review
  6. Novel MBritish journal of pharmacology · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jan JakubíkDepartment of Neurochemistry, Institute of Physiology Academy of Sciences of the Czech Republic v.v.i., Prague, Czech Republic. jakubik@biomed.cas.cz
Helena Janíčková
Alena Randáková
Esam E El-Fakahany
Vladimír Doležal
Czech Academy of Sciences, Institute of Physiology · CZCzech Academy of Sciences · CZUniversity of Minnesota · US

Funding

MUSCARINIC RECEPTOR SIGNALINGR01NS025743 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI EL-FAKAHANY, ESAM E · 1989 to 2006
$2.1M
NINDS NIH HHS NS25743NINDS NIH HHS R01 NS025743
6 · The paper itself

Abstract

Based on the kinetics of interaction between a receptor and G-protein, a myriad of possibilities may result. Two extreme cases are represented by: 1/Collision coupling, where an agonist binds to the free receptor and then the agonist-receptor complex "collides" with the free G-protein. 2/Pre-coupling, where stable receptor/G-protein complexes exist in the absence of agonist. Pre-coupling plays an important role in the kinetics of signal transduction. Odd-numbered muscarinic acetylcholine receptors preferentially couple to G(q/11), while even-numbered receptors prefer coupling to G(i/o). We analyzed the coupling status of the various subtypes of muscarinic receptors with preferential and non-preferential G-proteins. The magnitude of receptor-G-protein coupling was determined by the proportion of receptors existing in the agonist high-affinity binding conformation. Antibodies directed against the C-terminus of the α-subunits of the individual G-proteins were used to interfere with receptor-G-protein coupling. Effects of mutations and expression level on receptor-G-protein coupling were also investigated. Tested agonists displayed biphasic competition curves with the antagonist [(3)H]-N-methylscopolamine. Antibodies directed against the C-terminus of the α-subunits of the preferential G-protein decreased the proportion of high-affinity sites, and mutations at the receptor-G-protein interface abolished agonist high-affinity binding. In contrast, mutations that prevent receptor activation had no effect. Expression level of preferential G-proteins had no effect on pre-coupling to non-preferential G-proteins. Our data show that all subtypes of muscarinic receptors pre-couple with their preferential classes of G-proteins, but only M(1) and M(3) receptors also pre-couple with non-preferential G(i/o) G-proteins. Pre-coupling is not dependent on agonist efficacy nor on receptor activation. The ultimate mode of coupling is therefore dictated by a combination of the receptor subtype and the class of G-protein.

Indexed as

AnimalsBinding, CompetitiveCarbacholCHO CellsCricetinaeCricetulusGTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)HumansKineticsMutationN-MethylscopolamineReceptors, MuscarinicCarbacholGTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)N-MethylscopolamineReceptors, Muscarinic

Identifiers

PMID22110745
PMCPMC3218020
OpenAlexW2002241991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.